Warner Chilcott plc (NASDAQ:WCRX) delivered a profit and beat Wall Street’s expectations ... Click here for our fresh Feature Stock Pick now! HMS Holdings Corp. (NASDAQ:HMSY) delivered a profit and beat Wall Street’s expectations, …
Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced they have entered into a …
That was the hard lesson learned by Ireland's Warner-Chilcott (Nasdaq: WCRX), which saw its shares slump badly in the summer of 2011. Management eventually sought to goose the stock with some bold moves, but those efforts also …
DAVID'S, Bermuda, Dec. 15, 2008 (GLOBE NEWSWIRE) -- Warner Chilcott Limited (Nasdaq:WCRX) today announced that the Company ... domestic and international non-financial stocks on The NASDAQ Stock Market(r) based on …
Drug maker Actavis Inc. (ACT) agreed to acquire Warner Chilcott PLC (WCRX) for about $5 billion in an all-stock deal aimed at enlarging Actavis's portfolio of specialty pharmaceutical brands and shrinking its tax burden. The deal follows …
My picks are: Warner Chilcott Plc (NASDAQ:WCRX), Potash Corp./Saskatchewan (NYSE:POT) and First Solar, Inc. (NASDAQ:FSLR). Warner Chilcott has some amazing growth prospects, and looks to be severely undervalued. In the …
The Procter & Gamble Company (NYSE: PG) and Warner Chilcott plc (Nasdaq: WCRX) today announced an agreement for the sale of P&G's global pharmaceuticals business to Warner Chilcott for an up-front cash payment of $3.1 billion. …
Generic drugmaker Actavis[ticker symb=ACT] said Monday it's buying specialty drugmaker Warner Chilcott[ticker symb=WCRX] in an $8.5 billion deal, sending both stocks up in the stock market today. Actavis explained in its press …
NEW YORK Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would ... The Warner Chilcott plc (WCRX) deal will give Actavis an earnings jolt starting next year, said Susquehanna Financial Group …
Endo Health Solutions stock closed up 11 percent ... generic drug giant Teva. Warner Chilcott (NASDAQ:WCRX), formerly known as Galen, is an international pharmaceutical company based in Ireland that focuses on three core therapeutic …